GENE ONLINE|News &
Opinion
Blog

2026-06-02|

Zapata Computing Appoints Romero Fontalvo as Chief Product Officer and Nick Rotondi-Gray as Chief Revenue Officer

by GOAI
Share To

Zapata Computing announced two additions to its executive leadership team on Tuesday, appointing Romero Fontalvo as Chief Product Officer and Nick Rotondi-Gray as Chief Revenue Officer. These appointments aim to bolster the company’s product development and commercial operations as it continues its work in the quantum computing sector.

Fontalvo joins the company with a background in quantum technology, where he previously led initiatives focused on technical innovation and product strategy. In his new role, he oversees the development and execution of Zapata’s product roadmap. Rotondi-Gray transitions to the company from Palantir, bringing experience in scaling commercial organizations and managing enterprise-level partnerships. He now directs the company’s global sales and revenue-generating activities. Both executives report directly to the company’s leadership team as part of a broader effort to align the firm’s technical output with its market expansion goals.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 2, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Insilico Medicine’s ISM8969 Enters Phase 1 Trial, Advancing Brain-Penetrant NLRP3 Inhibitor for Neuroinflammation and CNS Disorders
2026-06-18
PNC Multifamily Capital Launches $251.4 Million Affordable Housing Investment Fund
2026-06-18
ArcelorMittal, thyssenkrupp, and voestalpine Call for EU Emissions Trading System Reforms to Protect Steel Competitiveness
2026-06-18
Hillman Group and Hillwood Begin Construction on Dallas-Fort Worth Multipurpose Facility
2026-06-18
Six Taipei Biotechs Head to BIO 2026 in San Diego, With Precision Medicine, Drug Delivery, and Bioprocess Innovation in Focus
2026-06-18
2026 Tang Prize in Biopharmaceutical Science Honors Three Pioneers of “Living Drug” Immunotherapies
2026-06-17
How One South Korean Hospital Built a Global Reputation Around a $5 Billion Surgical Standard
2026-06-16
Scroll to Top